(1 day, 9 hours ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Dr Simon Opher (Stroud) (Lab)
Good morning, Sir John. I thank the right hon. Member for Tatton (Esther McVey) for securing the debate.
Although there have been serious allegations about the MHRA and vaccines, I want to commend the enormous number of NHS staff who delivered the covid vaccine programme, which saved hundreds of thousands of lives—particularly those of older people. I do not want them to be denigrated by our debate.
I want to focus on the role of the MHRA with regard to antidepressants. I am the chair of the beyond pills all-party parliamentary group, and I chair our expert working group on antidepressant prescribing strategy. In particular, we want to highlight the problems associated with prescribed dependence-forming drugs such as antidepressants and the relevance of non-drug alternatives, such as social prescribing, talking therapies and access to nature.
Although antidepressants may help some people, overmedicalisation is a key concern. According to the latest figures, about 9.1 million people in England alone are on antidepressants and, shockingly, 187,000 patients under 19 were prescribed antidepressants in the last year. I am a GP with 30 years’ experience, and I specialise in mental health. I know that a significant number of patients are prescribed antidepressants when in fact they are feeling completely normal emotions in response to difficult life situations. They are not suffering from a medical condition and do not, in the main, need drug treatment.
The rising number of antidepressants prescribed brings up the issue of informed consent. Patients must be given clear information about the benefits and risks of antidepressants so that they can make a truly informed decision with their doctor about whether they want to take the drugs. That is where the MHRA comes in. We want to work constructively with the MHRA. I commend it on its recent initiatives recognising the need to strengthen the communication of risk around suicidality and sexual dysfunction with antidepressants. It should support the process of shared decision making between doctors and patients.
We also welcome the MHRA’s patient and public involvement and engagement plan, published on 5 November, which will take into account the lived experience of patients and carers in decision making. However, the MHRA needs to do that in other areas too, and there are still areas where we would like the risks to be communicated better, including akathisia—a distressing condition of such intense mental and physical disorder that people often say they want to take their own lives.
Another key issue is that patients are invariably not informed that they have an average chance of only one in eight that antidepressants will benefit their mental health.
One issue I am aware of in my constituency and across the United Kingdom is antidepressant drugs becoming addictive, which has a negative effect on people’s mental health, as the hon. Gentleman mentioned. When the Minister responds, perhaps he could give us some indication of how Government can address the issue of those who become addicted to the prescription medication they take daily.
The hon. Member is making a significant speech. One of my constituents on a selective serotonin reuptake inhibitor antidepressant committed suicide. Does he agree with me about the delays at the MHRA? There was significant evidence over a prolonged period of time that people on antidepressants could commit suicide when they come off, and yet nothing was done.
Dr Opher
That is absolutely true. There are higher risks of suicide when someone starts antidepressants and when they try to come off them, and patients are rarely informed about that. That is why we want more information from the MHRA in the pill packets.
Although we do not really know how antidepressants work, one accepted effect is that they dull emotions, which is called emotional blunting or numbness. That may be welcome for some, but for others it is profoundly distressing. Patient information leaflets might list effects such as apathy, indifference and lack of emotion or attachment, but patients have contacted the APPG to say that those terms do not convey the blunting of positive feelings as well as the negative ones.
One male patient in his 60s recently described the emotional blunting effect of his long-term antidepressants as
“suppressed love, joy, optimism, hope and creativity”.
He therefore decided to stop taking them, but like many others he suffered distressing and protracted withdrawal symptoms, with little support from his GP.
There is now another MHRA review into how well risks associated with withdrawals from antidepressants are communicated. Research suggests that between 34% and 50% of patients who try to come off them, as the right hon. Member for Tatton said, may experience quite severe withdrawal effects. Some 15% of patients who are long-term users—meaning they have used the drugs for more than a year—are likely to have severe withdrawal effects, and yet many of the drug companies do not accept that these drugs are addictive.
Since 2022, the National Institute for Health and Care Excellence has recognised that, for the patients most at risk of experiencing withdrawal, dosages need to be reduced in a slow, stepwise fashion called hyperbolic tapering. We call on the MHRA to urgently consider the need for licensing smaller doses of existing antidepressant drugs to enable that safer deprescribing. Currently, liquid antidepressants can be used, but they are off-label and incredibly expensive, which disincentivises GPs from prescribing them. It is also difficult to dilute them and get the correct dosage. We therefore need the MHRA to force drug companies to make smaller doses of tablets.
This is a tricky situation because antidepressants are licensed to treat indications such as depression, not for deprescribing. That means that very small doses of antidepressants cannot currently be created in tablet form under licence. Compounding pharmacies can make up little tablets, but they are unlicensed and cannot be routinely prescribed. A solution is urgently needed for licensing small doses of these drugs. Drug manufacturers should also be required to provide doses suitable for deprescribing for all new psychotropic drugs that will be licensed in the future. I hope the MHRA will seriously consider and act on those points.
As an addendum, I would be interested in the Minister’s view on the role of the MHRA in the regulation of AI in the NHS. As chair of the all-party parliamentary health group, I am chairing a meeting later to discuss the 44 recommendations that have recently been put forward.
(4 weeks, 1 day ago)
Commons ChamberMy hon. Friend is a doughty champion for her local area and for ensuring that we have services close to populations and close to where people live. I am very happy to meet her to discuss this.
Dr Simon Opher (Stroud) (Lab)
We commissioned the independent Fonagy review, which made it clear that mental distress has increased for young people and particularly young women. That is why we have already improved mental health support in schools for young people, and we will publish a new mental health strategy by Christmas.
Dr Opher
As the Minister knows, over 1 million young people are currently on the mental health waiting list. In Stroud, and in the South Bank centre, I am working with clinical teams and creative teams to offer early intervention to these young people, with social prescriptions for music, art, access to nature and exercise, and indeed stand-up comedy. Following the Fonagy review, which recommends support in the community with lower-level clinical services and on an earlier basis, does she support those initiatives, and may I meet her to discuss them?
Of course my hon. Friend can meet me to discuss stand-up comedy—I would like nothing more. Clinical services are important. We are already asking ICBs to reduce the longest waits for children and young people, and we have had a 14% decrease, but good mental health for young people goes way beyond that. My hon. Friend knows that I love art, sport and culture as much as he does.
(1 month ago)
Public Bill Committees
Jess Asato
Indeed I have, and I will come to that in a moment.
As I was saying, the Bill does not give sufficient voice to those who cannot speak for themselves—babies and infants. My amendment seeks to ensure that the Government will assess how successful services are in improving the physical, mental and emotional wellbeing of infants, parents and carers and, crucially, will assess our progress in tackling inequalities in the early years.
Although there is other legislation, such as the Equality Act, to guide secondary legislation, we know from bitter experience that future Governments could repeal legislation that has equality as its goal. Indeed, we are in difficult and divisive times in our country at the moment. There are those who would seek to repeal the Equality Act, thereby undoing any of the protective features that that Act would bring to this important Bill.
To anticipate future Government policies, the Bill must make reporting on inequality of outcomes paramount, because significant inequalities exist in many of the most fundamental measures of babies’ health and development. Black babies, for example, are more than twice as likely as white babies to be stillborn. Babies in the 10% most-deprived areas are more than twice as likely to die as babies in the 10% least-deprived areas. Babies growing up in poverty are more likely to experience domestic abuse in their family and are less likely to be breastfed.
At the moment, these inequalities, which are reported on by Government through auspices such as the Equality Act, might be identified, but in future there may be no requirement for that to be the case as part of the Bill. Simply showing that there is provision for babies, infants and their parents and carers could ensure that the Secretary of State is able to discharge their duty under the Bill, whether it actually operates to reduce inequalities or not. Under our current legislation, we still have deep inequalities, in part because the focus on reducing inequalities between areas has been lost—and lost deliberately. I think we ought to see whether we can return to making sure that that is the focus.
As it stands, the Bill does not explicitly require the Secretary of State to look at outcomes for babies and their parents, or at what those outcomes may indicate about the quality and availability of services. Although the views and experiences of parents and carers are incredibly important in understanding need, they do not paint the full picture and we cannot rely solely on them to analyse successes and failures of services. The public deserve to know the realities of inequalities in early childhood, and Governments must welcome robust scrutiny of their policies to help support babies.
The amendment also requires the Government to look at the wellbeing of parents. That is particularly important given the Maternal Mental Health Alliance report that said that one in four mothers experiences a mental health condition during pregnancy or after birth. Suicide remains the leading cause of death for women between six weeks and a year after giving birth. The amendment keeps the Bill flexible and streamlined, and I understand that it would not increase any financial cost of the Bill. It also clarifies the role of the Government in measuring success.
The Bill needs to be future-proof—indeed, the purpose of the Bill is to ensure, on a cross-party basis, that our services genuinely lead to a change in outcomes for babies, infants and children throughout their lives. It must stand the test of time, regardless of the colour, priorities or whims of future Governments. I have absolute faith in this Government and their commitment to early years investment, including the wonderful growth of Best Start family hubs, but we all saw how quickly the consensus behind Sure Start fell apart with a change in Government and how a generation of children and their parents were disadvantaged by its collapse.
Dr Simon Opher (Stroud) (Lab)
I thank the right hon. Member for New Forest West for bringing forward this excellent Bill. I await the technical appraisal of whether it needs to be amended, but we cannot deny that inequalities directly influence specific types of services. In my role as a GP, I have seen that children born in deprived areas need a much higher level of support from Sure Start-type services and video interactive guidance, because often relationships are poor. Those poor relationships can lead to children starting school not being able to hold a knife and fork or still being in nappies. Inequalities influence what types of services are needed. I accept the point from the right hon. Member that there may be technical guidance, but perhaps it should be integrated within the Bill.
(1 month ago)
Public Bill Committees
Jess Asato
Indeed I have, and I will come to that in a moment.
As I was saying, the Bill does not give sufficient voice to those who cannot speak for themselves—babies and infants. My amendment seeks to ensure that the Government will assess how successful services are in improving the physical, mental and emotional wellbeing of infants, parents and carers and, crucially, will assess our progress in tackling inequalities in the early years.
Although there is other legislation, such as the Equality Act, to guide secondary legislation, we know from bitter experience that future Governments could repeal legislation that has equality as its goal. Indeed, we are in difficult and divisive times in our country at the moment. There are those who would seek to repeal the Equality Act, thereby undoing any of the protective features that that Act would bring to this important Bill.
To anticipate future Government policies, the Bill must make reporting on inequality of outcomes paramount, because significant inequalities exist in many of the most fundamental measures of babies’ health and development. Black babies, for example, are more than twice as likely as white babies to be stillborn. Babies in the 10% most-deprived areas are more than twice as likely to die as babies in the 10% least-deprived areas. Babies growing up in poverty are more likely to experience domestic abuse in their family and are less likely to be breastfed.
At the moment, these inequalities, which are reported on by Government through auspices such as the Equality Act, might be identified, but in future there may be no requirement for that to be the case as part of the Bill. Simply showing that there is provision for babies, infants and their parents and carers could ensure that the Secretary of State is able to discharge their duty under the Bill, whether it actually operates to reduce inequalities or not. Under our current legislation, we still have deep inequalities, in part because the focus on reducing inequalities between areas has been lost—and lost deliberately. I think we ought to see whether we can return to making sure that that is the focus.
As it stands, the Bill does not explicitly require the Secretary of State to look at outcomes for babies and their parents, or at what those outcomes may indicate about the quality and availability of services. Although the views and experiences of parents and carers are incredibly important in understanding need, they do not paint the full picture and we cannot rely solely on them to analyse successes and failures of services. The public deserve to know the realities of inequalities in early childhood, and Governments must welcome robust scrutiny of their policies to help support babies.
The amendment also requires the Government to look at the wellbeing of parents. That is particularly important given the Maternal Mental Health Alliance report that said that one in four mothers experiences a mental health condition during pregnancy or after birth. Suicide remains the leading cause of death for women between six weeks and a year after giving birth. The amendment keeps the Bill flexible and streamlined, and I understand that it would not increase any financial cost of the Bill. It also clarifies the role of the Government in measuring success.
The Bill needs to be future-proof—indeed, the purpose of the Bill is to ensure, on a cross-party basis, that our services genuinely lead to a change in outcomes for babies, infants and children throughout their lives. It must stand the test of time, regardless of the colour, priorities or whims of future Governments. I have absolute faith in this Government and their commitment to early years investment, including the wonderful growth of Best Start family hubs, but we all saw how quickly the consensus behind Sure Start fell apart with a change in Government and how a generation of children and their parents were disadvantaged by its collapse.
Dr Simon Opher (Stroud) (Lab)
I thank the right hon. Member for New Forest West for bringing forward this excellent Bill. I await the technical appraisal of whether it needs to be amended, but we cannot deny that inequalities directly influence specific types of services. In my role as a GP, I have seen that children born in deprived areas need a much higher level of support from Sure Start-type services and video interactive guidance, because often relationships are poor. Those poor relationships can lead to children starting school not being able to hold a knife and fork or still being in nappies. Inequalities influence what types of services are needed. I accept the point from the right hon. Member that there may be technical guidance, but perhaps it should be integrated within the Bill.
(2 months, 1 week ago)
Commons Chamber
Steff Aquarone
I could not agree more. That is one of many respects in which rural and coastal communities around the country have much more in common with each other than with their inland neighbours just a few miles away. Theoretically available treatment becomes practically inaccessible if it requires a journey to be made without reliable toilet access, as in Ian’s case, and in cases where access to private transport is more limited, as in the cases that the right hon. Gentleman raises.
Kelly, Samantha, Ian and so many more are entitled to the same access to good treatment and the same chance of good health as people living in urban and inland communities. It is absolutely right for the Government to pursue this Bill, and I support their aim wholeheartedly, but I challenge them to assess the Bill based on who is left behind, not just who can be helped. Accept this amendment, or explain why rural and coastal communities do not merit explicit protection.
Dr Simon Opher (Stroud) (Lab)
My remarks will focus mainly on new clause 69, which is in my name. Getting rid of NHS England is one of the best things that this Government have done. As working clinicians, we can at least now get away from so much admin and management.
My amendment is a simple one about self-care and health literacy. Demand for healthcare has increased enormously. Since 2019, for example, GP consultations in Stroud have gone up 30%. When I started work as a GP, patients saw me on average three times a year; it is now about eight times a year. Indeed, A&E attendance has gone up 20% over the last decade, yet the health of the nation remains the same. This is the demand side of the NHS that we very rarely discuss, and this is what I am asking the Secretary of State to address.
Let me turn to the causes of this increase in demand. There is a concept in medicine called the symptom iceberg. Most of us get symptoms every day, but we do not go to the doctor. We only go to the doctor when we have certain symptoms, and it is a very small number of symptoms, but that has increased over the last 20 years. Then there is the role of something that we call lay referrals; people used to have mums who lived next door, but now they are often much further away. We are socially isolated in an atomised society. We also have a much higher expectation for our health. We cannot fault that, but it means that, for example, people go to the doctor with very minor things. There are also factors such as AI. In my surgery, we use AI, but I believe that creates its own demands. There is also good old Dr Google, who in this country is consulted over 50 million times every year—and those who go to Dr Google usually end up thinking that they have cancer or need an ambulance, so that is clearly driving demand.
There are also doctor factors. If we carry on treating sore throats with antibiotics, people will carry on coming back. Earaches generally get better, and people do not usually need to see a doctor for headaches. We are over-diagnosing and over-medicalising everything. NHS factors includes the algorithms for 111 and litigation. I would also like to talk about health literacy. That means knowing about our health, and understanding that we are not always in totally good health, but we do not have to consult the health service just because we are feeling a little bit low or a little bit tired.
One of my colleagues in Stroud, Dr Hugh van’t Hoff, started Facts4Life, a school-based education service that goes into schools. In the last 10 years, he has worked with over 200 primary schools. He has shown that if we teach young children about health and how it is normal sometimes to feel tired or have a sore throat—stuff like that—we can reduce consultations in the NHS. We can also teach children how to understand information on the internet, so that when they look at statistics, they know what they mean, instead of thinking, “Ooh, my risk of cancer has been doubled by doing this.” That is really important.
We are also over-medicalising patients. In this country, 9 million patients in England alone—one in five adults—are on antidepressants. That is a scandal.
Martin Wrigley
On interpreting statistics, does the hon. Gentleman agree that when it comes to data, GP confidentiality—in respect of the Palantir federated data platform, for example—is critical, certainly when we come to the single patient record, and that the Bill should not reduce confidentiality or data privacy to achieve the single patient record?
Dr Opher
I thank the hon. Member for that comment. He is right. NHS and GP data is a massive resource for our scientists in this country, and I agree with him that it should be owned by the UK. It should be a sovereign wealth issue. I would like to ensure that we realise that over time.
I will return to over-medicalisation. I would like to try to divert patients with mild to moderate mental health symptoms to social prescribing, such as access to nature, arts and culture and exercise—and indeed comedy. Let us try to reduce that figure of 9 million on antidepressants, so that people do not have to come back for review. There would be fewer harms, such as suicide, in the first couple of weeks. Let us also look again at neurodivergence, and try to look for a way of not medicalising so many children with the condition.
If we are serious about reducing waiting lists and making the NHS sustainable for the future, we cannot focus only on supply; we must address rising demand, too. Giving people the knowledge and confidence to look after their own health will empower them, free up clinicians to care for those who need them most, and ultimately build a healthier population. That is what new clause 69 seeks to achieve. I urge the Government to accept it.
Edward Morello (West Dorset) (LD)
Only half the children in my constituency have seen a dentist in two years. There has been a 20% decrease in NHS dental practices, and some constituents have written to me recently to say that they have been quoted in excess of £7,000 for the most basic of treatments. Amendment 47 would require the Government to establish training hubs in Dorset. It would ensure that dental hubs trained dentists for the future, and would mandate final-year trainees to provide supervised treatment to NHS patients straightaway. Trainees are already providing treatment for free, paid for by the taxpayer, as part of their training. Those appointments should be for the NHS, and not for private patients.
Amendment 48 would ensure that the dental funding underspend is redirected towards additional NHS appointments, shorter waiting times, outreach, and home and school-based services. Amendment 49 would require the dental funding formula to account for rurality, an ageing population, disability, transport costs and recruitment difficulties.
(4 months, 1 week ago)
Commons Chamber
Dr Simon Opher (Stroud) (Lab)
I thank my hon. Friend the Member for Tooting (Dr Allin-Khan) for securing this debate and for her years of work in the A&E at St George’s. Emergency care is in crisis in the NHS, and corridor care is just an overspill because we cannot cope. That is because we are doing a few things wrong that we could remedy.
I work as a GP. I did a surgery last Friday and actually tried to admit someone. I rang up A&E and they said, “Well, I wouldn’t send them up at the moment, as we’ve got a six-hour wait.” I realised that, quite often, we do not have an operable emergency care service, and this is something we need to work on.
I will briefly go through a few causes and then a few remedies, and the remedies could be clinical as well as organisational. First, we have an ageing population. Frailty is increasing. In Stroud alone, in four years, the number of over 90-year-olds went up 29% in just that short period of time. We have an enormous cohort of very elderly and frail people. Secondly, as we have heard, we have a lack of beds due to delayed discharge—I will not say any more on that. Thirdly, we have a lack of care beds in the community to enable discharge. There is also a lack of capacity in GP surgeries for on-the-day appointments. In my surgery, 45% of our appointments are on the day, but we obviously need to increase that so we can absorb the demand in primary care.
James Naish (Rushcliffe) (Lab)
I have sat through the debate, and I do not believe that community pharmacy or independent prescribing have been mentioned. Does my hon. Friend, with his experience as a GP, endorse the changes that the Government are making to maximise the use of pharmacists to deal with some of the pressures that he mentioned GPs face?
Dr Opher
That is absolutely true. We need to look at all the ways of reducing demand on GPs and, therefore, on A&E departments—that is what my speech is totally involved in—and pharmacies have a really good role to play.
There is another thing here, which was noticed in the doctors’ strike. When we have senior clinicians on the front door of A&E, that makes the department much quieter, because they make decisions quickly and can take a bit more clinical risk as they are more experienced. Perhaps we need to rearrange how care works in A&E departments so that we do not get a backlog.
I turn to the remedies. We are beginning to turn the NHS around—that is clear from working in it and from what my patients say. Things are beginning to change. We need to do a lot more, but we are investing a lot of money in it. We must not say that things are getting worse, because I believe they are slowly getting better.
As so many have said, we need to fix social care. We could have a system whereby the community is responsible for a patient as soon as they are ready for discharge. Perhaps the community should have to pay for the patient to remain in hospital after that to encourage it to get them out of hospital.
We must stop agency working in social care, because that is causing a huge amount of stress to carers. We need care to be based on a community model so that carers cover small areas and do not have huge travel times. We also have to improve GP access. I think we should also make it so that A&E departments see only accidents and real, genuine medical emergencies.
So we need a little bit of an increase in funding for primary care. We also need GPs to be assessing emergencies up until 10 o’clock at night to relieve the pressure on A&Es. There are a couple of other things. I have said about getting more experienced doctors involved earlier in the process, but we also need to invest in scanners—so many people in A&E are waiting for tests before they go home. Also, as my hon. Friend the Member for Tooting (Dr Allin-Khan) said, it is not appropriate to have mental health assessments in A&E; we need mental health assessment units, which I do believe the Government are bringing in.
There are a few clinical factors. Perversely, we need not to be so risk-averse. For example, admitting a patient for risk of falling is ridiculous, because they are more likely to fall in hospital than in their own home. Dementia fluctuates, so just because someone has seen a slight increase in confusion, that does not mean that they need a whole batch of tests. We need to treat dementia more holistically. Polypharmacy—that is old people on loads of drugs—causes about 10% of admissions, so let us reduce that.
We need good end-of-life care. Some 50% of people with cancer die in hospital—many of them face corridor care—and we need to reduce that, because most of them want to die at home. Every older person needs an advance care plan so that, when they become ill, we know whether they want to go to hospital. That is incredibly important in pathways of care.
Corridor care did not appear overnight, and it will not disappear overnight. But, by rebuilding the NHS from the community upwards, fixing social care and investing where it matters most, we can ensure that no patient is left waiting for care in a hospital corridor ever again.
(4 months, 3 weeks ago)
Commons Chamber
Rebecca Paul
I completely agree with my hon. Friend; a child of this age cannot possibly consent to the life-changing, irreversible changes that come from puberty blockers. We need to remember that almost all children who start puberty blockers go on to cross-sex hormones, and there is no going back from that.
We need to remember that we have already had a trial in the UK. When we started using puberty blockers in the UK after 2011, the preliminary results came out in 2015-16 and did not demonstrate psychological benefits, with some of the females actually suffering a worsening of symptoms, including a higher incidence of wanting to hurt or kill themselves. The results of the study, which were not formally published until 2020, demonstrated no statistically significant improvement in gender dysphoria or mental health outcomes. It is important to remember the early studies that told us that, in a majority of cases, going through puberty resolved gender distress. It follows, therefore, that stopping or delaying puberty using medication derails that natural desistance, essentially locking in.
Dr Simon Opher (Stroud) (Lab)
Speaking as a member of the political class and the medical class, may I ask the hon. Lady whether she would accept that it is better for politicians to accept advice from medical experts around medical issues?
Rebecca Paul
I thank the hon. Member for that excellent question. I obviously always respect and listen to different clinicians, but what is happening with this debate is that one set of clinicians with one view is being listened to. Let me remind everyone about lobotomies. Lots of very respected people came out for lobotomies; in fact, the person behind the idea won a Nobel prize. I think we would all agree that those clinicians got that wrong, so it is incumbent upon us in this House to always question. It is absolutely right that we listen to clinicians, but unfortunately we are seeing only one set of clinicians with one set of opinions being listened to here.
A Finnish study was published in April that looked at more than 2,000 adolescents and young adults who had been referred to gender services. It found that medical interventions did not reduce psychiatric problems and may even be associated with worsening mental health. How many times have we heard it said that puberty blockers offer a pathway towards improved mental health and reduced psychiatric distress for those struggling with gender identity? I have lost count. But there is hard evidence that not only says different; it says the opposite. I would be keen to understand from the Minister and the Secretary of State whether that study was taken into account before deciding to go ahead with the trial.
I want to point out that children and young people who grow up to be same-sex attracted are over-represented in this cohort, and that is something we need to think about. If we look at the case of Keira Bell, she was a lesbian struggling with her sexuality, and instead of people saying, “It’s okay to find other women attractive—there’s nothing wrong with that. You do not need to change your body,” they said, “Ah! You’ve got gender dysphoria.” They put her on puberty blockers, and then she went on to testosterone shots. She then had her breasts removed in a double mastectomy, and then she detransitioned. This is a deeply homophobic approach to healthcare. Those on the other side of the argument think they have the progressive position. I am sorry, but you are repeating mistakes that have been made historically—
(5 months, 2 weeks ago)
Commons Chamber
Dr Simon Opher (Stroud) (Lab)
It is a pleasure to speak in support of the Bill, which I believe has the power to transform patient care in the NHS. Particularly after the remarks of my hon. Friend the Member for Bury St Edmunds and Stowmarket (Peter Prinsley), the House will be aware that I also have a vested interest in this, as I have been a working GP in the NHS in Stroud for at least the last three decades. Indeed, I did a surgery last Friday, and I excitedly told the other doctors that we are going to have a single patient record. Instead of being excited, they said, “It’s about time.”
Those of us working in the NHS have been calling for a single patient record for years, so it is about time that a patient can tell their story just once, and about time a GP knows what a consultant is saying and the consultant knows what the GP is saying. It is about time that, when a patient gets admitted to A&E, the doctors know what the GP has already done, and that, when a patient gets referred to a psychiatrist, they know which antidepressants have been taken. As my hon. Friend said, patients struggle to understand how all the doctors do not know what is going on. We got rid of the fax machine in our surgery only last year, so we are fairly behind on communication, but the Bill lays the foundation for that to be remedied.
The benefits of the Bill for patients are huge—their medical knowledge at their fingertips, just as they are for clinicians and for integration. We cannot have integration without a decent single patient record. On research, our data is a national asset. I fear that a company such as Palantir owning our data is a derogation of our duty, and that we should use that data as a fantastic resource. I am also worried about Palantir’s involvement with death in Gaza and the infringement of civil liberties under the Immigration and Customs Enforcement agency in America. Also, at the Chelsea and Westminster hospital, it seems that the benefits that Palantir said it would bring to the operating theatre were not provable. The data is owned at the moment by GPs, and if there is a spillage of data, GP practices are unlimitedly liable. We must change that; otherwise, no one will become a GP partner. We must also be careful, because excessive and over-the-top safeguarding could obstruct the single patient record, and that would harm patient care.
Peter Prinsley
Does my hon. Friend agree that we must have a single patient record, not simply federated records from other sources?
Dr Opher
I do agree, although that is a much bigger job. At the moment, mental health uses a different system from the hospital, and it would be great to unite them. I agree with that, but whether it would possible in the next couple of years, I am not so sure.
Let me quickly go on to NHS England. The administrative burden on GP surgeries from NHSE has been huge, as my hon. Friend has mentioned, and it will be fantastic to get rid of that. When GPs undergo CQC inspections we have to do pointless protocols to fulfil the criteria, and they involve weeks of work. I want to make a little bid here for a much more supportive, lighter touch approach when looking at proper data around GP surgeries, which we would not have to prepare for. That would be very popular with GPs.
I warmly welcome this Bill. It is about time we reduced the ridiculous administration around patients and allowed clinicians to properly care for patients, and it is about time we had a single patient record.
(6 months, 3 weeks ago)
Commons Chamber
Olly Glover
The hon. Gentleman is absolutely correct to say that awareness raising and increasing understanding are key priorities in dealing with SUDEP and epilepsy in general.
Patients with epilepsy carry a risk of premature death that is, on average, two to three times higher than in the general population, as has been outlined by Frontiers in Epidemiology. What is most devastating is the knowledge that 60% of epilepsy-related deaths each year are believed to be preventable, according to the European Journal of Neurology, with SUDEP accounting for many of these deaths.
Dr Simon Opher (Stroud) (Lab)
I thank the hon. Gentleman for bringing this really essential debate to the House. My constituent Emma Taylor tragically lost her daughter at the age of 19 and she now campaigns tirelessly for SUDEP Action as a policy champion. Does the hon. Gentleman agree with her on the need for the Government to promote proper first aid seizure training?
Olly Glover
I very much agree with the hon. Gentleman’s constituent. I thank her for her tireless campaigning and offer my condolences for her loss.
My Oxfordshire constituency of Didcot and Wantage is the home to SUDEP Action, a charity that is local, national and international in its impact. In 1995, five bereaved women came together around a kitchen table to found the charity in tribute to Alan, aged 27; Matthew, 21; Natalie, 22; and William, 22—all of whom had died, with the condition unrecognised beforehand. Jane Hanna, Sheila Pring, Catherine Brookes, Sue Kelk and Jennifer Preston faced despair together and chose to build hope. Since 2020, SUDEP Action has worked alongside the Epilepsy Research Institute to identify tackling epilepsy deaths as a No. 1 research priority.
The key challenge that SUDEP Action faces is that research insight does not reliably or quickly reach neurology consultations, primary care or social care. National Institute for Health and Care Excellence guidelines exist, but services are inadequately supported to implement them. Jane Hanna from SUDEP Action told me that my own constituents face nine-month waits for a first seizure clinic and waits of nine to 12 months for follow-ups. She told me that waits of this magnitude, such as we are experiencing in my constituency, are unsafe. Her partner Alan waited for four months and died suddenly five months later. Waits such as these are not confined to my constituency; they are reflective of a structural problem across the country.
Free safety tools exist to tackle the lack of knowledge and the complacency around seizures and SUDEP, but systemic issues are difficult to shift because of poor access, poor medicine management, failure to communicate risk and poor recording of deaths. An independent review was named after Clive Treacey. Clive died at 47 in 2017 in a hospital setting where he had lived for 10 years. The report on his life is shocking for this country in the 21st century. The Minister might be aware of the debate secured last year by the hon. Member for Lichfield (Dave Robertson), who I am pleased to see in his place tonight, and of the response from the Under-Secretary of State for Health and Social Care, the hon. Member for Glasgow South West (Dr Ahmed), who supported the Clive Treacey checklist.
(8 months ago)
Commons ChamberThe right hon. Gentleman makes a very important point about bureaucracy. Many of the reforms that we are pushing for in the contract are designed to reduce bureaucracy. For example, by moving to a single point of access and embedding advice and guidance in the contract, we will reduce the number of transactions. In the current system, the practice needs to put in a request for a £20 payment each time it provides advice and guidance; we are embedding that and streamlining it.
The other point to make is that at the heart of our 10-year plan is the shift from analogue to digital. I have seen some extraordinarily effective artificial intelligence technology around ambient voice services, which enable an entire consultation to be recorded and put directly into the system, thereby saving the GP hours at the end of the day in writing up notes.
Dr Simon Opher (Stroud) (Lab)
I declare an interest as a working GP in the NHS. I probably would not be standing here if general practice had not been decimated over the last 14 years. I welcome the £485 million of extra funding, and I also welcome the fact that the capacity and access money is being channelled back into emergency GP action, so increasing the number of appointments, and increasing continuity of care by bringing back the family doctor. May I have some reassurance that the processes of advice and guidance and the referral mechanisms will not get in the way of Jess’s rule, which is about referring patients on their third presentation without any particular diagnosis?
My hon. Friend is absolutely right. The £292 million we have made available for advice and guidance is repurposed funding from the capacity and access improvement payments, so it is part of incentivising improved access and better patient outcomes. I can absolutely assure him that Jess’s rule remains fixed as a really important part of ensuring that it is three strikes and a referral. Whatever happens, that will be a top priority throughout the embedding of this contract.